Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation

British Journal of Haematology

Volumn 104, Issue 3, 1999, Pages 569-573

  Okamoto, Shinichiro ^a,c   Takahashi, Satoshi ^b   Wakui, Masatoshi ^a   Ishida, Akaru ^a   Tanosaki, Ryuji ^a   Ikeda, Yasuo ^a   Asano, Shigetaka ^b  

^a School of Medicine   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Allogeneic bone marrow transplantation; Chemosensitization; Conditioning; G CSF; Myelodysplastic syndrome

Indexed keywords

CYTARABINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE PAIN; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0033025246     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01205.x     Document Type: Article

References (12)

1. Anderson, J.E., Appelbaum, F.R., Fisher, L.D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Doney, K., Martin, P.J., Sanders, J.E., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P., Hansen, J.A. & Storb, R. (1993) Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood, 82, 677-681.
2. Anderson, J.E., Appelbaum, F.R., Schoch, G., Gooley, T., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Chauncey, T.R., Clift, R.A., Deeg, J., Doney, K., Flowers, M., Hansen, J.A., Martin, P.J., Matthews, D.C., Nash, R.A., Sanders, J.E., Shulman, H., Sullivan, K.M., Witherspoon, R.P. & Storb, R. (1996) Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total body irradiation and analysis of prognostic factors. Journal of Clinical Oncology, 14, 220-226.
3. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
4. Collins, R.H., Shpilberg, O., Drobyski, W.R., Porter, D.L., Giralt, S., Champlin, R., Goodman, S.A., Wolff, S.N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetril, A., Antin, J.H. & Nemunaitis, J. (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 15, 433-444.
5. DeWitte, T., Zwaan, F., Hermans, J., Vernant, J., Kolb, H., Vossen, J., Lonnqvist, B., Beelen, D., Ferrant, A., Gmur, J., Liu Yin, J., Troussard, X., Cahn, J., Van Lint, M. & Gratwohl, A. (1990) Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). British Journal of Haematology 74, 151-155.
6. Hiraoka, A., Masaoka, T., Shibata, H., Kasai, M., Moriyama, Y., Kato, S., Kodera, Y., Matsuyama, N., Hirabayashi, A., Kanamaru, A., Dohy, H., Shimosaka, A. & Takaku, F. (1995) Five years follow-up of a randomized placebo-controlled study with filgrastim (recombinant human granulocyte colony stimulating factor) in patients receiving allogeneic bone-marrow transplantation. Blood, 86, 222a.
7. Kumar, M., Saleh, A., Rao, P.V., Ochoa, S., Meyers, L., Miller, A. & Graham-Pole, J. (1998) Toxicity associated with high-dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation. Bone Marrow Transplantation, 19, 1061-1064.
8. Locatelli, F., Niemeyer, C., Angelucci, E., Bender-Götze, C., Burdach, S., Ebell, W., Friedrich, W., Hasle, H., Hermann, J., Jacobsen, N., Klingebiel, T., Kremens, B., Mann, G., Pession, A., Peters, C., Schmid, H., Stary, J., Suttorp, M., Uderzo, C.T., van't Veer-Korthof, E.T., Vossen, J., Zecca, M., Zimmerman, M., and the European Working Group on Myelodysplastic Syndrome in Childhood (1997) Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. Journal of Clinical Oncology, 15, 566-573.
9. Mattijssen, V., Schattenberg, A., Schaap, N., Preijers, F. & de Witte, T. (1997) Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndrome. Bone Marrow Transplantation, 19, 791-794.
10. Miyauchi, J., Kelleher, C.A., Wang, C., Minkin, S. & McCulloch, E.A. (1989) Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. Blood, 73, 1272-1278.
11. Ratanatharathorn, V., Karanes, C., Uberti, J., Lum, L.G., de Planque, M.M., Schultz, K.R., Cronin, S., Dan, M.E., Mohamed, A., Hussein, M. & Sensenbrenner, L.L. (1993) Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood, 81, 2194-2199.
12. Takahashi, S., Okamoto, S.I., Shirafuji, N., Ikebuchi, K., Tani, K., Shimane, M., Matsudaira, T., Irie, S., Tsuruta, T., Matsuishi, E., Ogura, H., Kouzai, Y., Kodo, H., Tojo, A., Satoh, N., Ozawa, K. & Asano, S. (1994) Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplantation, 13, 239-245.